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A western diet, believed to be a risk factor for prostate cancer
(Giles and Ireland, 1997; Bosland et al, 1999) may increase risk by
increasing androgen concentrations in the serum and prostate
(Montie and Pienta, 1994). Data from prospective studies suggest
that prostate cancer risk may be increased by high serum concen-
trations of bioavailable testosterone (Gann et al, 1996) and
androstanediol glucuronide (A-diol-g), a serum marker of 5a-
reductase activity and intraprostatic dihydrotestosterone (DHT)
(Eaton et al, 1999). One prospective study has also found circu-
lating levels of insulin-like growth factor-I (IGF-I), a polypeptide
which interacts with androgens to stimulate cell proliferation, to be
higher among men who subsequently developed prostate cancer
than among controls (Chan et al, 1998).
The nutritional determinants of circulating hormone levels in men
are poorly understood; some previous studies suggested that a vege-
tarian diet, low in saturated fat and high in dietary fibre, might
reduce androgen levels, but the results have been inconsistent and
based on small numbers (Deslypere and Vermeluen, 1984; Howie
and Shultz, 1985; Bélanger et al, 1989; Key et al, 1990; Pusateri et
al, 1990). We are not aware of any previous data on IGF-I concen-
trations in vegetarian and vegan men. We report here the results of a
large cross-sectional study of serum concentrations of sex hormones
and related proteins among 696 men of whom 226 were meat-eaters,
237 were vegetarians and 233 were vegans. We estimated that the
study would have 80% power to detect 10% differences in hormone
concentrations between diet groups at the 5% significance level.
MATERIALS AND METHODS
750 white male subjects were selected from the Oxford UK
component of the European Prospective Investigation into Cancer
and Nutrition (EPIC), and were for the current study if they had
donated a blood sample prior to 1998. Subjects were excluded if
they had a self-reported history of cancer (n = 16), or were taking
medication known to influence hormone levels (n = 16). We also
excluded those who had insufficient serum available for analysis
(n = 16) or had an estimated energy intake of < 3.1 and > 18.40 mJ/
day (n = 5). One further individual was excluded due to an SHBG
level above the upper detection limit of 280 nmol/l.
The present study includes 696 men of whom 226 were meat-
eaters, 237 were vegetarians and 233 were vegans, recruited
between 1994 and 1997. 30 ml blood samples were collected for
each subject and sent in the mail to the EPIC laboratory in Norfolk
and aliquoted into plasma, serum, buffy coat and erythrocytes.
Serum samples were stored in liquid nitrogen tanks at –196°C.
Nutrient intakes were estimated from a validated semi-quantitative
food frequency questionnaire by multiplying the nutrient content
of a specific portion size of each food by the frequency of
consumption (Bingham et al, 1997). Details of medical history and
lifestyle characteristics were also recorded.
Assays for serum IGF-I, sex hormone binding globulin
(SHBG), testosterone (T), A-diol-g, and luteinizing hormone (LH)
were performed in the Clinical Biochemistry Laboratory at the
John Radcliffe Hospital, Oxford in 1998. Plasma cholesterol
assays were performed using automated enzymatic procedures at
the Biochemistry Laboratory at Kings College, London in 1999.
Each assay batch included equal numbers of meat-eaters, vegetar-
ians and vegans, selected at random. All intra-assay coefficients of
variation were less than 12%. An estimate of the concentration of
free testosterone (FT) was derived from the known concentrations
of T and SHBG and assuming albumin concentration to be
constant between individuals, using the formula based on the law
of mass action (Södergaard et al, 1982).
Hormone concentrations and nutrient intakes were logarithmi-
cally or square-root transformed to approximate normal distribu-
tions. The mean hormone concentrations and their corresponding
95% confidence intervals (95% CI) are presented as back-
transformed values. Mean values adjusted for covariates were
calculated by analysis of covariance.
RESULTS
Anthropometric and dietary characteristics are shown in Table 1.
Vegetarians and vegans were significantly younger and had a
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Examination of nutrient intakes showed that vegetarians and
vegans had lower intakes of energy, protein, total fat, saturated and
monounsaturated fatty acids, and alcohol (each as percent energy)
and lower intakes of dietary cholesterol compared to meat-eaters.
Conversely, vegans had higher intakes of polyunsaturated fatty
acids (% energy), polyunsaturated:saturated fatty acid ratio and
non-starch polysaccharides than meat.
All mean hormone concentrations are adjusted for age, smoking
status, vigorous exercise, time of day of venipuncture, time since
last eaten at venipuncture and time between venipuncture and
blood processing. Mean hormone concentrations are presented
with and without adjustment for BMI (Table 2). Vegan men had on
average 9% lower IGF-I levels than meat-eaters (P < 0.01) and 8%
lower levels than vegetarians (P < 0.01); adjustment for BMI made
little difference to these values. Prior to adjustment for BMI,
SHBG levels in vegans were 16% higher than in meat-eaters (P <
0.0001), and 12% higher than in vegetarians (P = 0.0008); adjust-
ment for BMI reduced these differences to 6% (P = 0.02) and 10%
(P = 0.004), respectively. Vegans had 13% higher T concentration
than meat-eaters (P = 0.0001) and 8% higher than vegetarians (P =
0.001); adjustment for BMI reduced these differences to 6% (P =
0.07) and 7% (P = 0.02), respectively. Since an increase in SHBG
generally causes an increase in total T, we examined differences in
mean T concentration after additionally adjusting for SHBG. This
adjustment substantially reduced the difference in T between
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Table 1 Anthropometric and nutritional characteristics by dietary group
Variable Meat-eaters Vegetarians Vegans P valuea
(n = 226) (n = 237) (n = 233)
Age (yrs) 52.8 (51.2–54.3) 46.3 (44.8–47.9) 42.9 (41.3–44.4) < 0.0001
Weight (kg) 82.4 (80.9–83.4) 74.4 (72.9–75.9) 71.8 (70.4–73.3) < 0.0001
Height (m) 1.78 (1.77–1.79) 1.78 (1.77–1.79) 1.78 (1.77–1.79) 0.4739
BMIb 26.1 (25.7–26.5) 23.4 (22.0–23.8) 22.7 (22.3–23.1) < 0.0001
Energy (MJ) 10.3 (9.91–10.7) 8.88 (8.57–9.20) 8.08 (7.79–8.38) < 0.0001
Protein (% energy) 16.6 (16.3–16.8) 13.2 (12.9–13.4) 12.7 (12.4–13.0) < 0.0001
Total fat (% energy) 34.0 (33.2–34.8) 31.0 (30.3–31.8) 29.9 (29.1–30.7) < 0.0001
Saturated fatty acids (% energy) 11.8 (11.5–12.1) 8.71 (8.38–9.03) 4.87 (4.55–5.20) < 0.0001
Monounsaturated fatty acids (% energy) 10.9 (10.5–11.2) 8.61 (8.26–8.95) 8.57 (8.22–8.92) < 0.0001
Polyunsaturated fatty acids (% energy) 5.39 (5.06–5.72) 6.12 (5.79–6.44) 8.17 (7.85–8.50) < 0.0001
P:S ratioc 0.49 (0.44–0.54) 0.78 (0.73–0.83) 1.71 (1.66–1.76) < 0.0001
Cholesterol (mg/d) 327 (301–355) 112 (108–127) 20.8 (19.2–25.5) < 0.0001
Alcohol (% energy) 5.83 (5.07–6.58) 4.30 (3.57–5.03) 3.96 (3.22–4.70) 0.0012
Non-starch polysaccharides (g/d) 17.7 (16.9–25.8) 23.8 (22.8–24.8) 27.5 (26.3–28.7) < 0.0001
Age and anthropometric measurements are presented as arithmetic means and corresponding 95% confidence interval (CI); nutrients were natural log-
transformed and are presented as geometric means and 95% CI. aP value is test of heterogeneity, bBMI: body mass index = weight [kg]/height [m],
cpolyunsaturated:saturated fatty acid ratio.
Table 2 Mean hormone concentrations in three dietary groups
Hormone Meat-eaters Vegetarians Vegans P valueb
(n = 226)a (n = 237)a (n = 233)a
IGF-I (nmol/l)
Unadjusted for BMI 20.1 (19.3–20.8) 20.1 (19.4–20.8) 18.5 (17.8–19.2) 0.002
Adjusted for BMI 20.3 (19.5–21.1) 20.0 (19.3–20.7) 18.4 (17.7–19.1) 0.002
SHBG (nmol/l)
Unadjusted for BMI 42.6 (40.2–45.2) 44.6 (42.2–47.0) 50.9 (48.1–53.7) 0.001
Adjusted for BMI 45.7 (43.1–48.4) 43.6 (41.4–46.0) 48.7 (46.0–51.4) 0.017
T (nmol/l)
Unadjusted for BMI 19.3 (18.3–20.3) 20.5 (19.6–21.4) 22.3 (21.3–23.4) 0.003
Adjusted for BMI 20.3 (19.3–21.3) 20.1 (19.2–21.0) 21.7 (20.7–22.7) 0.046
FT (nmol/l)
Unadjusted for BMI 0.40 (0.38–0.42) 0.42 (0.40–0.44) 0.42 (0.40–0.45) 0.137
Adjusted for BMI 0.42 (0.40–0.44) 0.43 (0.41–0.45) 0.44 (0.42–0.46) 0.471
A-diol-g (nmol/l)
Unadjusted for BMI 8.93 (8.40–9.47) 8.45 (7.97–8.93) 8.63 (8.14–9.14) 0.443
Adjusted for BMI 8.72 (8.18–9.28) 8.49 (8.01–8.98) 8.80 (8.29–9.32) 0.646
LH (IU/l)
Unadjusted for BMI 5.29 (4.91–5.65) 5.27 (4.96–4.61) 5.30 (4.96–5.66) 0.996
Adjusted for BMI 5.43 (5.06–5.82) 5.23 (4.92–5.57) 5.20 (4.87–5.56) 0.632
Total cholesterol (nmol/l)
Unadjusted for BMI 4.94 (4.81–5.07) 4.55 (4.44–4.66) 4.08 (3.97–4.19) < 0.0001
Adjusted for BMI 4.87 (4.87–5.00) 4.57 (4.46–4.69) 4.12 (4.01–4.24) < 0.0001
Back-transformed means presented with 95% CI in parentheses. Values are adjusted for age (in categories of 20–29, 30–39, 40–49, 50–59, 60–69, 70+),
smoking status (never, past, < 10 cigarettes/day, 10+ cigarettes/day), vigorous exercise (< 2, 2–4 5+ hours/week), time of day of venipuncture (< 10, 10–13.29,
13.30+ hours), time since last meal at venipuncture (< 1.5, 1.5–3, 3+ hours) and time between blood draw and processing (1, 2, 3, 4+ days). aInsufficient serum
led to IGF-I measurement being unavailable in 1 subject, SHBG in 9 subjects, T in 20 subjects, FT in 25 subjects, A-diol-g in 5 subjects, LH in 20 subjects and
total cholesterol in 8 subjects. bP value is test of heterogeneity.the three diet groups (adjusted means were 20.3, 20.5 and
21.2 nmol/l in meat-eaters, vegetarians and vegans respectively,
test for heterogeneity; P = 0.312). There were no significant differ-
ences in calculated FT, A-diol-g or LH between dietary groups.
There were substantial differences in plasma total cholesterol, with
vegans having 17% lower mean values than meat-eaters
(P < 0.0001), and 10% lower values than vegetarians (P < 0.0001),
and adjustment for BMI made little difference to these values.
DISCUSSION
This study is the largest to date to investigate differences in serum
hormone concentrations between meat-eaters, vegetarians and
vegans. The significant 9% lower IGF-I concentration among
vegan men compared to meat-eaters has not been reported before.
IGF-I may play an important role in the aetiology of prostate
cancer via its ability to interact with androgens to stimulate
prostatic cell growth (Cohen et al, 1994), but its determinants are
poorly understood. Chan et al (1998) found that men who subse-
quently developed prostate cancer had 8% higher serum IGF-I
concentrations than men who remained healthy, suggesting that
the 9% difference we observed is large enough to significantly
alter prostate cancer risk.
SHBG was significantly higher in the vegans than in the meat-
eaters, leading to a corresponding increase in T in order to main-
tain constant levels of FT, a pattern which has been found in
previous smaller observational studies (Key et al, 1990; Pusateri et
al, 1990). The differences in SHBG concentrations between
dietary groups were reduced but not eliminated by adjusting for
differences in BMI, suggesting that nutritional factors specific to a
vegan diet may be important determinants of circulating SHBG
levels, over and above their effect on BMI.
The significantly lower plasma total cholesterol concentration
found among vegans compared to both vegetarians and meat-
eaters, and the lower concentration in vegetarians compared to
meat-eaters has been well-established in previous observational
studies (Thorogood et al, 1987). These results confirm that large
differences in lipid intake and lipoprotein physiology do exist
between these dietary groups, but that these differences are not
associated with circulating androgen concentrations.
The results did not support the hypothesis that meat-eaters have
higher levels of bioavailable androgens than non meat-eaters. No
differences in hormone levels were found between meat-eaters and
lacto-ovo-vegetarians, suggesting that vegetarian diets may not
alter prostate cancer risk, but the relatively low IGF-I levels in
vegans might reduce their risk of prostate cancer. Prospective data
have shown that vegetarians do not have significantly lower
prostate cancer mortality rates than comparable non-vegetarians
(Key et al, 1999), but these subjects were predominantly lacto-
ovo-vegetarians and there are, as yet, no data on prostate cancer
rates among vegans.
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